HOOKIPA Pharma (NASDAQ:HOOK) just reported results for the fourth quarter of 2023.
- HOOKIPA Pharma reported earnings per share of -22 cents. This was below the analyst estimate for EPS of -19 cents.
- The company reported revenue of $7.41 million.
- This was 62.79% better than the analyst estimate for revenue of $4.55 million.